
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+1
American Gene Technologies International Inc. (AGTTM) is a private biotechnology company pursuing cures and treatments for infectious diseases, cancers, and monogenic disorders. AGTTMs emerging gene and cell therapeutics programs are designed to: Create immunotherapy for HIV disease with gene-modified T cells Activate innate T cell immunity capable of killing all tumor cells with its vector used in immuno-oncology Treat PKU by bringing a functional gene into cells that express a dysfunctional gene due to mutation Advance clinically to provide human proof of concept For over a decade, AGTTM has developed, tested, and banked thousands of lentiviral vectors that can be...
Hiv and hepatitis-c viral therapeutics,cancer therapeutics,autosomal disorders,immuno-oncology,gene therapy,and cell therapy
American gene technologies international inc operates in the Biotechnology research industry.
American gene technologies international inc's revenue is 11m - 100m
American gene technologies international inc has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.